Filing Flows › Chemours (CC) › Q3 2025
Chemours (CC) Q3 2025 earnings results (third quarter 2025)
10-Q filed Nov 6, 2025
Chemours (CC) reported revenue of $1.5B for the third quarter 2025 (Q3 2025), -0.9% from a year earlier and -7% from the quarter before. Operating margin was 3.4%, net earnings $60.0M (4.0% of revenue).
Chemours, Q3 2025: revenue $1.5B (-0.9% year over year), operating margin 3.4%, net earnings $60.0M, operating cash flow $146M. The chart follows the revenue to costs, profit and cash.
| Q3 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.5B | -7% | -0.9% |
| Gross profit | $233M | -16% | -19% |
| Operating profit | $51.0M | — | — |
| Net earnings | $60.0M | — | — |
| Operating cash flow | $146M | +57% | +5% |
| Free cash flow | $105M | +110% | +67% |
What changed
Revenue was $1.5B in Q3 2025, down 1% year over year and down 7% from the previous quarter. All Segments was the largest line at 99% of revenue. All Segments lost $0.01B year over year (down 1%), 85% of the total change.
Gross margin was 15.6%, down 3.4 points from a year earlier. Operating profit was $0.05B, a 3.4% margin (up 5.5 points year over year). Operating expenses fell 43% while revenue fell 1%. Net earnings were $0.06B. The effective tax rate was -17.6%.
Operating cash flow was $0.15B (up 5% year over year), 243% of net earnings. Non-cash charges added back $0.08B of depreciation and amortization and $0.01B of share-based compensation. Capital expenditures of $0.04B left free cash flow of $0.10B.
Questions
What was Chemours' revenue in the third quarter 2025?
Chemours (CC) reported revenue of $1.5B for the third quarter 2025 (Q3 2025), -0.9% from a year earlier and -7% from the quarter before.
Was Chemours profitable in the third quarter 2025?
Operating profit was $51.0M (3.4% of revenue) and net earnings $60.0M.
Source: Chemours 10-Q on SEC EDGAR.